Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xencor Inc
(NQ:
XNCR
)
17.34
+0.38 (+2.24%)
Streaming Delayed Price
Updated: 11:42 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xencor Inc
< Previous
1
2
3
4
5
6
Next >
Xencor to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023
January 31, 2023
Via
Benzinga
Why Shares of Zencor Rose This Week
January 26, 2023
The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago.
Via
The Motley Fool
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13, 2023
Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.
Via
MarketBeat
Xencor's Return On Capital Employed Overview
December 01, 2022
Via
Benzinga
Xencor's Return On Capital Employed Overview
August 11, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via
Benzinga
Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates
January 09, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting
December 12, 2022
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
Xencor to Present at Upcoming Investor Conferences
November 10, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb® Programs at the SITC Annual Meeting
November 10, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Third Quarter 2022 Financial Results
November 07, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor’s IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study
November 07, 2022
From
Xencor, Inc.
Via
Business Wire
Earnings Scheduled For November 7, 2022
November 07, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
Via
Benzinga
Xencor Earnings Preview
November 04, 2022
Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report an...
Via
Benzinga
Xencor to Present New Clinical Data from the Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin’s Lymphoma at the American Society of Hematology Annual Meeting
November 03, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022
October 31, 2022
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting
October 05, 2022
From
Xencor, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
September 21, 2022
Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...
Via
Benzinga
Xencor Appoints Nancy Valente, M.D., to Board of Directors
September 09, 2022
From
Xencor, Inc.
Via
Business Wire
Xencor Reports Second Quarter 2022 Financial Results
August 03, 2022
From
Xencor, Inc.
Via
Business Wire
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022
July 27, 2022
From
Xencor, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
June 13, 2022
During Monday's trading, 1214 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 10, 2022
On Friday, 422 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
During the Thursday's session, 100 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
On Wednesday, 73 stocks hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.